Calcagno Research and Development

Gresham, Oregon 97030

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Dermatitis, Atopic

Studies at this site

• 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis — Completed
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification — Stopped early
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis — Completed